Morgan Kelly

Morgan Kelly serves as the primary procurement lead for the Medical Supply Chain Pharmacy FSA under the Department of Defense’s DLA Troop Support, responsible for ensuring the secure, timely acquisition of mission-critical pharmaceuticals and medical formulations to sustain global military readiness. They manage a diverse portfolio of acquisitions spanning sterile injectables, oral solid dosages, topical anesthetics, and antiparasitic formulations, coordinating end-to-end contracting processes from requirements validation to contract award and performance monitoring. Their role is central to maintaining the resilience and responsiveness of the DoD’s pharmaceutical supply chain, particularly in contingency and deployed environments where uninterrupted access to medications is essential to troop health and operational continuity. Kelly’s contractor relationships are primarily with manufacturers and wholesale distributors specializing in pharmaceutical production and distribution. They engage with a broad base of vendors including GMP-certified pharmaceutical manufacturers, licensed merchant wholesalers of drugs and sundries, and specialized suppliers of botanical and compounded formulations. While no single contractor dominates the award landscape, Kelly consistently prioritizes vendors with robust cold-chain logistics capabilities, FDA compliance, and validated supply chain security protocols to meet stringent DoD standards for drug integrity and traceability. Kelly’s procurement activities reflect a strong preference for open competition, with 100% of acquisitions classified as “No Set-Aside,” indicating a focus on technical capability and supply reliability over socioeconomic preferences. This approach underscores a mission-driven emphasis on ensuring uninterrupted access to life-saving medications, even if it means prioritizing established, high-capacity suppliers over small business set-asides. The agency’s procurement activity is heavily concentrated in NAICS 325412 (Pharmaceutical Preparation Manufacturing), followed by 424210 (Drugs and Druggists’ Sundries Merchant Wholesalers), reflecting deep expertise in sourcing FDA-regulated drug products and managing wholesale distribution networks. Kelly’s technical domain expertise lies in navigating complex regulatory frameworks—including cGMP, DEA controls, and DoD-specific pharmaceutical logistics requirements—to deliver mission-critical therapeutics across austere and high-threat operational environments.